Regadenoson Injection, Solution
Product Images NDC 60505-6116

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Regadenoson (NDC 60505-6116). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Regadenoson-injection-carton Label (Regadenoson Injection Carton Label)

This is a description of Regadenoson Injection, a pharmacologic stress agent used for diagnostic purposes. Each mL contains 0.08 mg regadenoson and other ingredients, and it is intended for intravenous use only. The injection is single-dose, pre-filled in a syringe, and must be discarded if unused. It is sterile, non-pyrogenic, and preservative-free. The recommended storage temperature is between 5 and 30°C. The text also includes some unreadable characters, making the description incomplete.*

FDA Label Image

Structure (Structure)

FDA Label Image

Regadenoson-injection-0.4mg/5ml-syringe-label (Syringe Label 02)

This is a medication that has an NDC number of 60505.6116.0. It is intended for intravenous use and for pharmacologic stress only. It's a 0.4mg/5mL (0.08mg/mL) solution intended to be administered in a single dose of 5mL. The solution is manufactured by Gland Pharma Limited, with manufacturing lot number 10TAPIRRSTIER. It is manufactured for Apotex Corp. in Weston, Florida. The expiration date is not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.